{"id":1964,"date":"2026-05-07T12:00:12","date_gmt":"2026-05-07T12:00:12","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/05\/07\/phase-2-pegsebrenatide-trial-begins-dosing-in-progressive-ms\/"},"modified":"2026-05-07T12:00:12","modified_gmt":"2026-05-07T12:00:12","slug":"phase-2-pegsebrenatide-trial-begins-dosing-in-progressive-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/05\/07\/phase-2-pegsebrenatide-trial-begins-dosing-in-progressive-ms\/","title":{"rendered":"Phase 2 pegsebrenatide trial begins dosing in progressive MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/07\/phase-2-pegsebrenatide-trial-begins-dosing-progressive-ms\/\" title=\"Phase 2 pegsebrenatide trial begins dosing in progressive MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"450\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/05\/iStock-2244140593-800x450.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A 3D illustration of a gray syringe pen with the letters spelling &quot;GLP 1&quot; used for the treatment of diabetes.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"161978\" \/><\/a><\/p>\n<p>The first participant has been dosed in an investigator-initiated Phase 2 clinical trial testing Neuraly&#8216;s experimental medication pegsebrenatide as a potential treatment for progressive forms of multiple sclerosis (MS). Called TAG-MS (NCT07497399), the study is being led by Ellen Mowry, MD, at Johns Hopkins University in Maryland, with additional clinical sites expected to participate. The [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/07\/phase-2-pegsebrenatide-trial-begins-dosing-progressive-ms\/\">Phase 2 pegsebrenatide trial begins dosing in progressive MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/07\/phase-2-pegsebrenatide-trial-begins-dosing-progressive-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The first participant has been dosed in an investigator-initiated Phase 2 clinical trial testing Neuraly&#8216;s experimental medication pegsebrenatide as a potential treatment for progressive forms of multiple sclerosis (MS). Called TAG-MS (NCT07497399), the study is being led by Ellen Mowry, MD, at Johns Hopkins University in Maryland, with additional clinical sites expected to participate. The&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1965,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1964","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1964"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1964\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1965"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}